Improving Speech in Noise Perception for Individuals With Age-related Hearing Loss
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: transcutaneous auricular vagus nerve stimulation, Sham Control.
- Who it may be relevant to
- Registry conditions: Presbycusis. Basic parameters: 55 years — 80 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- United States
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Overview
Hearing loss, especially for speech perception in the presence of noise, may lead older individuals to withdraw from social situations. While hearing aids help amplify sound and are useful in many situations, they can be ineffective in noisy contexts. The proposed pilot study will evaluate taVNS for improving speech in noise perception in adults with age-related hearing loss.
Interventions
- Device transcutaneous auricular vagus nerve stimulation
active electrical stimulation applied to the cymba conchae of the left ear - Device Sham Control
electrical stimulation applied to a location on the ear not innervated by the auricular vagus
Primary outcome measures
- Speech in noise performance [Time frame: 2 weeks]
Eligibility criteria
Inclusion criteria
- Adults 55-80 years old
- Normal hearing or age-related hearing loss (with or without hearing aids)
Exclusion criteria
- History of traumatic brain injury or noise trauma
- Implanted medical devices (eg., pacemaker) or ferrous metal
- Known history of heart conditions
- Medications that impact neurotransmitters released by vagus nerve stimulation
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: Yes
Study design
- Allocation
- Randomized
- Model
- Parallel assignment
- Masking
- Double blind
- Primary purpose
- Treatment
Study locations
United States · 1 center
- UF Health at the University of Florida — Gainesville
Identifiers
NCT: NCT07192757 · IRB202500769